Tonix Pharmaceuticals stock halted ahead of FDA approval news
Joseph Mansueto, the Executive Chairman of Morningstar , Inc. (NASDAQ:MORN), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Mansueto sold a total of 17,670 shares of Morningstar’s common stock over two days, February 24 and February 25, 2025, generating approximately $5.7 million. The company, currently valued at $13.73 billion, has demonstrated strong financial performance with a 12.5% revenue growth in the last twelve months.
The sale was executed in multiple transactions, with prices ranging from $321.34 to $323.92 per share. Following these transactions, Mansueto holds 10,077,018 shares directly. The sales were conducted under a Rule 10b5-1 trading plan, which allows major shareholders to set up a predetermined plan to sell stocks, helping to avoid concerns about insider trading. InvestingPro analysis indicates the company maintains a "GOOD" overall financial health score, with particularly strong profit and growth metrics.
Additionally, Mansueto’s indirect holdings, managed through trusts, remain substantial, with 4,836,106 shares held in grantor retained annuity trusts and another 150,000 shares held in trusts for his children’s benefit. The company has maintained dividend payments for 16 consecutive years, with a 21.3% dividend growth in the last twelve months. For more detailed insights and exclusive financial metrics, check out InvestingPro, which offers 8 additional key tips about MORN’s performance and outlook.
In other recent news, Morningstar, Inc. has announced a strategic partnership with SS&C Technologies, integrating Morningstar’s Direct Advisory Suite with SS&C’s Black Diamond (NASDAQ:CLAR) Wealth Platform. This collaboration aims to enhance advisor productivity by providing access to Morningstar’s portfolio analytics and research tools directly within the Black Diamond platform, which serves approximately 2,700 wealth management firms. In a separate development, Morningstar has named Michael Holt as its new chief financial officer, effective January 1, 2025. Holt, who has been with Morningstar since 2008, will succeed Jason Dubinsky and will lead the global finance organization, reporting to CEO Kunal Kapoor.
Additionally, Morningstar has made a regulatory filing with the Securities and Exchange Commission, releasing an 8-K form that includes an Investor Q&A section. This document addresses investor questions and provides transparency into the company’s operations and strategic outlook. The filing also contains forward-looking statements, highlighting potential risks such as cybersecurity threats and regulatory changes. Morningstar has emphasized these statements involve uncertainties and advises investors to consult further disclosures in its SEC filings. The company continues to focus on strategic partnerships and leadership transitions to drive growth and enhance its service offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.